John L. Stebbins

2.7k total citations
39 papers, 2.0k citations indexed

About

John L. Stebbins is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, John L. Stebbins has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in John L. Stebbins's work include Melanoma and MAPK Pathways (9 papers), Cell death mechanisms and regulation (9 papers) and Ubiquitin and proteasome pathways (7 papers). John L. Stebbins is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Cell death mechanisms and regulation (9 papers) and Ubiquitin and proteasome pathways (7 papers). John L. Stebbins collaborates with scholars based in United States, South Korea and United Kingdom. John L. Stebbins's co-authors include Maurizio Pellecchia, John C. Reed, Russell Dahl, Paul B. Fisher, Surya K. De, Bainan Wu, Rupesh Dash, Swadesh K. Das, Aras Emdadi and Jason Cellitti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

John L. Stebbins

39 papers receiving 2.0k citations

Peers

Countries citing papers authored by John L. Stebbins

Since Specialization

Citations

This map shows the geographic impact of John L. Stebbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Stebbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Stebbins more than expected).

Fields of papers citing papers by John L. Stebbins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John L. Stebbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Stebbins. The network helps show where John L. Stebbins may publish in the future.

Co-authorship network of co-authors of John L. Stebbins

This figure shows the co-authorship network connecting the top 25 collaborators of John L. Stebbins. A scholar is included among the top collaborators of John L. Stebbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John L. Stebbins. John L. Stebbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Charting Salivary Oxytocin Across an Episode of Naturally Occurring Partnered Sex 2025 ·Archives of Sexual Behavior ·Amanda Denes, (unknown), John P. Crowley, (unknown), Talea Cornelius, John L. Stebbins, Steve W. Granger	1
2	Exploring the role of oxytocin in communication processes: A test of the post sex disclosures model 2021 ·Communication Monographs ·Amanda Denes, John P. Crowley, (unknown), (unknown), John L. Stebbins, Steve W. Granger	1
3	Salivary total Immunoglobulin G as a surrogate marker of oral immune activity in salivary bioscience research 2019 ·Brain Behavior & Immunity - Health ·Jenna L. Riis, Crystal I. Bryce, John L. Stebbins, Douglas A. Granger	10
4	Standardizing Size- and Shape-Controlled Synthesis of Monodisperse Magnetite (Fe₃O₄) Nanocrystals by Identifying and Exploiting Effects of Organic Impurities 2017 ·ACS Nano ·Liang Qiao, Zheng Fu, Ji Li, (unknown), Ming Zeng, John L. Stebbins, Paras N. Prasad, Mark T. Swihart	130
5	Design, Synthesis and Bioevaluation of an EphA2 Receptor‐Based Targeted Delivery System 2014 ·ChemMedChem ·Elisa Barile, Si Wang, Swadesh K. Das, Roberta Noberini, Russell Dahl, John L. Stebbins, Elena B. Pasquale, Paul B. Fisher, Maurizio Pellecchia	33
6	Structure-Based Design of Covalent Siah Inhibitors 2013 ·Chemistry & Biology ·John L. Stebbins, Eugenio Santelli, Yongmei Feng, Surya K. De, (unknown), Khatereh Motamedchaboki, Bainan Wu, Ze’ev A. Ronai, Robert Liddington, Maurizio Pellecchia	46
7	Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth 2012 ·Cancer Research ·Albert G. Remacle, Vladislav S. Golubkov, Sergey A. Shiryaev, Russell Dahl, John L. Stebbins, Andrei V. Chernov, Anton Cheltsov, Maurizio Pellecchia, Alex Y. Strongin	110
8	Targeted Delivery of Paclitaxel to EphA2-Expressing Cancer Cells 2012 ·Clinical Cancer Research ·Si Wang, Roberta Noberini, John L. Stebbins, Swadesh K. Das, Ziming Zhang, Bainan Wu, Sayantan Mitra, Sandrine Billet, (unknown), Neil A. Bhowmick, Shinichi Kitada, Elena B. Pasquale, Paul B. Fisher, Maurizio Pellecchia	56
9	Sabutoclax, a Mcl-1 Antagonist, Inhibits Tumorigenesis in Transgenic Mouse and Human Xenograft Models of Prostate Cancer 2012 ·Neoplasia ·Roger S. Jackson, William J. Placzek, (unknown), (unknown), Chia-Yi Chu, Jun Wei, John L. Stebbins, Shinichi Kitada, (unknown), John C. Reed, Leland W.K. Chung, Maurizio Pellecchia, Neil A. Bhowmick	37
10	Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda -7/IL-24–mediated toxicity 2011 ·Proceedings of the National Academy of Sciences ·Rupesh Dash, Belal Azab, Bridget A. Quinn, Xue‐Ning Shen, Xiangyang Wang, Swadesh K. Das, Mohamed Rahmani, Jun Wei, Michael Hedvat, Paul Dent, Igor P. Dmitriev, David T. Curiel, Steven Grant, Bainan Wu, John L. Stebbins, Maurizio Pellecchia, John C. Reed, Devanand Sarkar, Paul B. Fisher	101
11	Design, synthesis, and structure–activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase 2011 ·Bioorganic & Medicinal Chemistry ·Surya K. De, Elisa Barile, (unknown), John L. Stebbins, Jason Cellitti, Thomas Machleidt, Coby B. Carlson, Li Yang, Russell Dahl, Maurizio Pellecchia	13
12	An Optically Pure Apogossypolone Derivative as Potent Pan-Active Inhibitor of Anti-Apoptotic Bcl-2 Family Proteins 2011 ·SHILAP Revista de lepidopterología ·Jun Wei, John L. Stebbins, Shinichi Kitada, Rupesh Dash, Dayong Zhai, William J. Placzek, Bainan Wu, Michele F. Rega, Ziming Zhang, Elisa Barile, Li Yang, Russell Dahl, Paul B. Fisher, John C. Reed, Maurizio Pellecchia	40
13	Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics 2010 ·Journal of Cellular Physiology ·(unknown), Seok‐Geun Lee, Timothy P. Kegelman, Zhao-zhong Su, Swadesh K. Das, Rupesh Dash, Santanu Dasgupta, Paola M. Barral, Michael Hedvat, Paul Diaz, John C. Reed, John L. Stebbins, Maurizio Pellecchia, Devanand Sarkar, Paul B. Fisher	318
14	BI-97C1, an Optically Pure Apogossypol Derivative as Pan-Active Inhibitor of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins 2010 ·Journal of Medicinal Chemistry ·Jun Wei, John L. Stebbins, Shinichi Kitada, Rupesh Dash, William J. Placzek, Michele F. Rega, Bainan Wu, Jason Cellitti, Dayong Zhai, Li Yang, Russell Dahl, Paul B. Fisher, John C. Reed, Maurizio Pellecchia	97
15	Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins 2009 ·Molecular Cancer Therapeutics ·Jun Wei, Shinichi Kitada, Michele F. Rega, Aras Emdadi, Hongbin Yuan, Jason Cellitti, John L. Stebbins, Dayong Zhai, Jiazhi Sun, Li Yang, Russell Dahl, Ziming Zhang, Bainan Wu, Si Wang, (unknown), Nicholas J. Lawrence, Saı̈d M. Sebti, John C. Reed, Maurizio Pellecchia	51
16	Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors 2009 ·Bioorganic & Medicinal Chemistry ·Surya K. De, (unknown), John L. Stebbins, Li‐Hsing Chen, Jason Cellitti, Thomas Machleidt, Elisa Barile, Megan Riel‐Mehan, Russell Dahl, Li Yang, Aras Emdadi, (unknown), Maurizio Pellecchia	16
17	Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors 2009 ·Bioorganic & Medicinal Chemistry ·Surya K. De, Li‐Hsing Chen, John L. Stebbins, Thomas Machleidt, Megan Riel‐Mehan, Russell Dahl, (unknown), Hongbin Yuan, Elisa Barile, Aras Emdadi, (unknown), Maurizio Pellecchia	24
18	Identification of a new JNK inhibitor targeting the JNK-JIP interaction site 2008 ·Proceedings of the National Academy of Sciences ·John L. Stebbins, Surya K. De, Thomas Machleidt, Barbara Becattini, Jesús Vázquez, Christian Kuntzen, Li‐Hsing Chen, Jason Cellitti, Megan Riel‐Mehan, Aras Emdadi, Giovanni Solinas, Michael Karin, Maurizio Pellecchia	157
19	Structure-based discovery of a new class of Bcl-xL antagonists 2007 ·Bioorganic Chemistry ·Michele F. Rega, Marilisa Leone, Da‐Woon Jung, (unknown), John L. Stebbins, Maurizio Pellecchia	18
20	A Structure-based Approach to Retinoid X Receptor-α Inhibition 2006 ·Journal of Biological Chemistry ·John L. Stebbins, Dawoon Jung, Marilisa Leone, Xiao-kun Zhang, Maurizio Pellecchia	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact